Navigation Links
Landmark Sleep Apnea, Heart Failure Study Recruits 1,000th Participant
Date:5/21/2012

MUNICH, May 21, 2012 /PRNewswire/ --

SERVE-HF, the largest study to investigate if treatment of predominant central sleep apnea (CSA) improves survival and outcomes of patients with stable heart failure, has enrolled its 1,000th participant. The study, sponsored by ResMed Ltd., is the largest of its kind. This milestone brings the SERVE-HF study, which began in 2008, one step closer to its target of approximately 1,250 participants.

Principal investigator Prof. Martin Cowie, of the Royal Brompton Hospital in London said, "SERVE-HF is the world's largest study for any aspect of sleep-disordered breathing [SDB], and it has involved significant collaboration among sleep physicians, respiratory physicians and cardiologists across Europe."

Co-principal investigator, Prof. Helmut Teschler, Medical Director at the Department of Pneumology, Ruhrland Clinic, Essen, added, "This study is so important because SDB in heart failure patients is a very common occurrence, particularly in men.  Given that at least 50% of men with heart failure also suffer from moderate to severe SDB, treatment of SDB could be vital to improving heart failure outcomes in the future."

Patients with heart failure may have an abnormal waxing and waning breathing pattern called Cheyne-Stokes respiration (CSR) with CSA.  Previous studies have demonstrated that such patients have a poor quality of life as well as increased mortality, but that they may do better and live longer if they are treated with assisted ventilation during sleep.

The SERVE-HF study hopes to provide more conclusive evidence of the health benefits of treating SDB in heart failure patients, and on a much larger scale.  The study is being conducted at more than 80 sites in Germany, France, the UK, Norway, Sweden, Denmark, Finland, Australia and the Czech Republic.

The primary goal of the study is to determine whether managing CSR-CSA with ResMed's proprietary adaptive
'/>"/>

SOURCE ResMed
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
2. Trapollo LLC Teams with Humana Cares for Landmark Telehealth Deployment to 1600 Humana Subscribers
3. Landmark Study Finds Expensive Catheter Procedure to Close Hole in Heart No More Effective Than Medical Therapy to Prevent Strokes
4. The Appellate Division of State Supreme Court has Upheld a Landmark 2010 Products Liability Verdict Which Found Cybex International Responsible for Catastrophic Injuries Suffered by a Cheektowaga Woman
5. HSCA, Group Purchasing Industry Endorse Landmark Environmental Tool From Practice Greenhealth to Help Guide Selection and Procurement of Environmentally Preferable Products for Hospitals
6. Kimberly-Clark Health Care Receives Landmark FDA Clearance for Pediatric Face Mask
7. Landmark Stryker Trial Establishes Coiling as Safe and Effective Treatment for Ruptured and Unruptured Aneurysms
8. SurgiCount Medical Announces Expanded Honor Roll Hospital Users, Landmark Product Usage Milestones Achieved
9. AVAC Says Results of New PrEP Trials Provide Clear Evidence that Antiretroviral Drugs for Prevention Can Help End the AIDS Epidemic; Calls for Quick Action to Move Landmark HIV Prevention Results Toward Lifesaving Programs
10. Consortium Opens Landmark Personalized Medicine Childrens Cancer Trial
11. Landmark Patents Issued for ViewRay Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... Ga., March 4, 2015  Halyard Health, Inc. (NYSE: ... and provided its 2015 outlook and related key planning ... Halyard Health as we report our fourth quarter results, ... Chairman and CEO. "We executed a smooth separation from ... the spin-off. We delivered sales growth and margin improvement ...
(Date:3/4/2015)... BOSTON , March 4, 2015   InspireMD, ... leader in embolic protection systems ("EPS"), today announced that ... up to approximately 34 million shares of common stock ... shares of common stock in a public offering.  The ... price of $0.40 per share, and each purchaser will ...
(Date:3/4/2015)... 4, 2015 Oramed Pharmaceuticals Inc. ... clinical-stage pharmaceutical company focused on the development of oral ... participate in the upcoming 27 th Annual ROTH ... Dana Point, CA.  Dr. Michael Berelowitz ... will present a corporate overview on March 10, 2015. ...
Breaking Medicine Technology:Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 2Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 3Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 4Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 5Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 6Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 7Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 8Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 9Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 10Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 11Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 12Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 13Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 14Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 15Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 16Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 17Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 18Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 19Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 20Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 21Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 22Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 23Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 24Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 25Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 26Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 27Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 28Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 29Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 30Halyard Health, Inc. Announces Year-End 2014 Results and 2015 Outlook 31InspireMD Announces Public Offering for Approximately $13.5 Million 2InspireMD Announces Public Offering for Approximately $13.5 Million 3InspireMD Announces Public Offering for Approximately $13.5 Million 4Oramed to Present at the ROTH Conference 2Oramed to Present at the ROTH Conference 3
... SIRO Clinpharm, a leading full service Clinical Research Organization ... SIRO has developed a long term plan to align with ... charter is to transform SIRO into a global leader in ... continuing to build and enhance the biopharma service catalog for ...
... 2012  Amgen Inc. ("Amgen") (NASDAQ: AMGN ) announced ... tender offer (the "Offer") by a wholly owned subsidiary, "Merger ... Micromet, Inc. ("Micromet") (NASDAQ: MITI ) for $11.00 ... 12:00 midnight, New York City time, at the end of ...
Cached Medicine Technology:SIRO Clinpharm Announces Appointment of Gopakumar Menon as Chief Executive Officer to Lead the Global Clinical Research Organization 2Amgen Completes Tender Offer for Outstanding Shares of Micromet, Inc. 2Amgen Completes Tender Offer for Outstanding Shares of Micromet, Inc. 3Amgen Completes Tender Offer for Outstanding Shares of Micromet, Inc. 4
(Date:3/4/2015)... March 04, 2015 State officials have ... the School of Public Health at Georgia State University, ... were awarded by Georgia’s Division of Family and Children ... the DFCS Call Center. , The 1-800-CHILDREN Helpline ... providing information and referral services that promote the wellbeing ...
(Date:3/4/2015)... March 04, 2015 The popular all-natural ... their new L-Style Revolution™ Program. The customized program provides ... women of all health and fitness levels to follow ... faster than traditional methods. , “We’re really proud to ... plans based on award winning techniques to help people ...
(Date:3/4/2015)... March 04, 2015 Columbus is no stranger ... prevalence of cocaine addiction, and suffers from the potential ... on Feb. 27th, the DEA revealed that Kratom is a ... herbal tea; the newly introduced herb from Southeast Asia acts ... heightened doses. WKYC notes kratom foments symptoms similar to heroin ...
(Date:3/4/2015)... Vancouver, BC (PRWEB) March 04, 2015 ... Research , millions of people in the U.S. suffer ... acid reflux. Medications are commonly prescribed to control acid ... invasive surgical procedures can overly correct the problem and ... A Market Opportunity, GERD occurs when the lower esophageal ...
(Date:3/4/2015)... Jeannie Mai, TV personality, fashion maven, and co-host ... of the print publication. Mai embraces the overall theme of ... for clothes and personal care products. In an exclusive interview, ... to an organic diet. She mentions, “Having an organic lifestyle ... but also now as I’m a full time student at ...
Breaking Medicine News(10 mins):Health News:State Funds Child Abuse Helpline Housed At Georgia State 2Health News:The Makers of Liporidex, The Popular Sports Nutrition Supplement Brand, Launches Its New L-Style Revolution™ Diet & Exercise Program That Promises Turbo Charged Results 2Health News:Columbus, OH Combats the Sale of Kratom as a Drug, Harbor Village Detox Stresses Caution 2Health News:New and Proven Acid Reflux Treatments Offer Relief to Millions of Americans 2Health News:New and Proven Acid Reflux Treatments Offer Relief to Millions of Americans 3
... Today, SOUTH SAN FRANCISCO, Calif., Feb. 28 Cell,Genesys, ... the,fourth quarter and full year ended December 31, 2007. The ... diluted share), for the fourth,quarter of 2007, compared to a ... the corresponding period in 2006. The net loss for the,year ...
... MOUNTAIN VIEW, Calif., Feb. 28 MAP,Pharmaceuticals, Inc. (Nasdaq: ... quarter and year ended December 31, 2007., The ... December 31, 2007,was $14.9 million and $40.1 million, respectively, ... periods in 2006. MAP,Pharmaceuticals had cash, cash equivalents and ...
... Feb. 28 Closer,analysis of the patent office "non-final" ... the Wisconsin Alumni Research Foundation (WARF),shows the following gains ... was abandoned showing it was underserved,and new amended claims ... all embryonic stem cells no matter how,they are derived, ...
... 28, 2008) -- NewYork-Presbyterian Hospital/Weill Cornell Medical Center announced ... Forbes Holdings Inc., has made a $50 million gift ... NewYork-Presbyterian Hospital and Weill Cornell Medical College, in support ... the world. The gift will establish the Ronald O. ...
... COLUMBIA, Mo. University of Missouri scientist Kattesh ... using gold salts, soybeans and water. Kattis research ... could have major applications in several disciplines. , ... small they cannot be seen by the naked ...
... YORK, February 28 Ten prominent journalists from the ... for the fourth annual TempletonCambridge Journalism Fellowships in Science ... 2004, the fellowships include a program of research and ... The 2008 fellows were announced today by the New ...
Cached Medicine News:Health News:Cell Genesys Reports Fourth Quarter and Year-End 2007 Results 2Health News:Cell Genesys Reports Fourth Quarter and Year-End 2007 Results 3Health News:Cell Genesys Reports Fourth Quarter and Year-End 2007 Results 4Health News:Cell Genesys Reports Fourth Quarter and Year-End 2007 Results 5Health News:Cell Genesys Reports Fourth Quarter and Year-End 2007 Results 6Health News:MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results 2Health News:MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results 3Health News:MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results 4Health News:MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results 5Health News:MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results 6Health News:MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results 7Health News:Closer Analysis Shows Consumer Groups Make Gains in Stem Cell Patent Challenges Against WARF; Appeal Still Planned Against Narrowed Claims 2Health News:$50 million gift to NewYork-Presbyterian Hospital/Weill Cornell Medical Center 2Health News:$50 million gift to NewYork-Presbyterian Hospital/Weill Cornell Medical Center 3Health News:$50 million gift to NewYork-Presbyterian Hospital/Weill Cornell Medical Center 4Health News:$50 million gift to NewYork-Presbyterian Hospital/Weill Cornell Medical Center 5Health News:Breakthroughs in nanotechnology on edge of 'knowledge frontier' 2Health News:Breakthroughs in nanotechnology on edge of 'knowledge frontier' 3Health News:4th annual Templeton-Cambridge fellowships awarded to 10 noted journalists 2Health News:4th annual Templeton-Cambridge fellowships awarded to 10 noted journalists 3Health News:4th annual Templeton-Cambridge fellowships awarded to 10 noted journalists 4
The Biomet® CHS is indicated for intertrochanteric, subtrochanteric and basilar neck fractures of the proximal femur....
... procedures. Part of the osi modular ... top provides a complete, powered, orthopedic ... provides for skin or skeletal traction ... femur, supine or lateral im nailing; ...
... ElectroMagnetic Field (PEMF) bone growth stimulation delivered ... for long bone and small bone nonunions. ... orthopedic brace, or clothing without lessening its ... one compact, lightweight unit including success rates ...
Guardsman Femoral Interference Screw is specifically designed for endoscopic femoral fixation where graft protection is needed....
Medicine Products: